Owner Pharmaco Investments, Inc

Service Davies Collison Cave

Various Convention priority claimed: 23 May 2001, United States of America, No. 76/261636, in respect of class 5.* Convention priority claimed: 23 May 2001, United States of America, No. 76/261634, in respect of COMPUTER SOFTWARE FOR PRESENTING A MEDICAL QUESTION

Class 5 Medical diagnostic assays

Class 9 Computer database of patient medical information; computer software for presenting a medical questionnaire for the collection of patient medical information; computer software for database management, namely, the extraction, analysis and storage of patient's medical information; assays of cellular and bimolecular parameters; chemical analysis equipment; scientific instruments, namely micro-volume laser scanning cytometers; nanoparticulate identification tags; bioassay kits; nanoscale electronic components; computer-based medical questionnaire for the collection of clinical information accessible via a global computer network

Class 35 Maintaining files and records concerning the medical condition of individuals and patient medical information

Class 42 Providing an on-line computer database in the field of patient medical information; providing temporary use of on-line non-downloadable software for presenting a medical questionnaire for the collection of patient medical information; chemical analysis, namely, assays of cellular and biomolecular parameters; new drug development services and technical consulting and research in the field of clinical strategies for drug development; organism phenotyping and technical consulting and research in the field of organism phenotyping; identifying candidates for medical clinical trials and technical consulting and research in the field of identifying candidates for medical clinical trial and treatments; chemical analysis of compounds; performing bioassays for others; biological marker identification and technical consulting, research and development in the field of biological marker identification; research and development of new drugs and diagnostics; technical consulting and research in the field of determining targets for drugs and performing the foregoing services for others